Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Barbara S Gillespie

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Hemodialysis International. International Symposium on Home Hemodialysis|January 30, 2007
Anemia management in chronic kidney diseaseBarbara S Gillespie, Jula K Inrig, Lynda A Szczech
Kidney International|January 23, 2026
ICD-10 codes for APOL1-mediated kidney diseaseBarry I Freedman, Barbara S Gillespie, Ogo I Egbuna
Therapeutic Innovation & Regulatory Science|September 19, 2018
Bowel Preparations for Colonoscopy: A Regulatory PerspectiveKlaus Gottlieb, J Rick Turner, Barbara S Gillespie, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 30, 2010
TROPICS 1: a phase III, randomized, double-blind, placebo-controlled study of tenecteplase for restoration of function in dysfunctional central venous cathetersNashat Gabrail, Eric Sandler, Veena Charu, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 17, 2011
A phase III, open-label, single-arm study of tenecteplase for restoration of function in dysfunctional central venous cathetersCameron Tebbi, John Costanzi, Robert Shulman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 6, 2010
A phase III, randomized, double-blind, placebo-controlled study of tenecteplase for improvement of hemodialysis catheter function: TROPICS 3James Tumlin, Jesse Goldman, David M Spiegel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 19, 2007
Risk for cardiovascular outcomes among subjects with atherosclerotic cardiovascular disease and greater-than-normal estimated glomerular filtration rateJula K Inrig, Barbara S Gillespie, Uptal D Patel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 7, 2007
Mortality, kidney disease and cardiac procedures following acute coronary syndromeJula K Inrig, Uptal D Patel, Libbie P Briley, et al.
Glomerular Diseases|March 17, 2025
Designing Clinical Trials for the Treatment of Membranous Nephropathy in the Anti-Phospholipase A2 Receptor 1 Era: Results of a NephCure Membranous Nephropathy WorkshopMarco Prunotto, Patrick H Nachman, Barbara S Gillespie, et al.
Kidney International|March 15, 2025
Designing clinical trials for the treatment of membranous nephropathy in the anti-PLA2R era: results of a Nephcure membranous nephropathy workshopMarco Prunotto, Patrick H Nachman, Barbara S Gillespie, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Hemodialysis International. International Symposium on Home Hemodialysis|January 30, 2007
Anemia management in chronic kidney diseaseBarbara S Gillespie, Jula K Inrig, Lynda A Szczech
Kidney International|January 23, 2026
ICD-10 codes for APOL1-mediated kidney diseaseBarry I Freedman, Barbara S Gillespie, Ogo I Egbuna
Therapeutic Innovation & Regulatory Science|September 19, 2018
Bowel Preparations for Colonoscopy: A Regulatory PerspectiveKlaus Gottlieb, J Rick Turner, Barbara S Gillespie, et al.
Journal of Vascular and Interventional Radiology : JVIR|November 30, 2010
TROPICS 1: a phase III, randomized, double-blind, placebo-controlled study of tenecteplase for restoration of function in dysfunctional central venous cathetersNashat Gabrail, Eric Sandler, Veena Charu, et al.
Journal of Vascular and Interventional Radiology : JVIR|May 17, 2011
A phase III, open-label, single-arm study of tenecteplase for restoration of function in dysfunctional central venous cathetersCameron Tebbi, John Costanzi, Robert Shulman, et al.
Clinical Journal of the American Society of Nephrology : CJASN|February 6, 2010
A phase III, randomized, double-blind, placebo-controlled study of tenecteplase for improvement of hemodialysis catheter function: TROPICS 3James Tumlin, Jesse Goldman, David M Spiegel, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 19, 2007
Risk for cardiovascular outcomes among subjects with atherosclerotic cardiovascular disease and greater-than-normal estimated glomerular filtration rateJula K Inrig, Barbara S Gillespie, Uptal D Patel, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|November 7, 2007
Mortality, kidney disease and cardiac procedures following acute coronary syndromeJula K Inrig, Uptal D Patel, Libbie P Briley, et al.
Glomerular Diseases|March 17, 2025
Designing Clinical Trials for the Treatment of Membranous Nephropathy in the Anti-Phospholipase A2 Receptor 1 Era: Results of a NephCure Membranous Nephropathy WorkshopMarco Prunotto, Patrick H Nachman, Barbara S Gillespie, et al.
Kidney International|March 15, 2025
Designing clinical trials for the treatment of membranous nephropathy in the anti-PLA2R era: results of a Nephcure membranous nephropathy workshopMarco Prunotto, Patrick H Nachman, Barbara S Gillespie, et al.
Pageof 2